PET心肌灌注显像对血运重建患者选择的影响
研究纳入14,649例接受82Rb静息/负荷PET MPI的患者,检验已知冠心病、左室射血分数储备(LVEF-R)与90天血运重建的三阶交互作用。在中位随访3.4年中,无既往冠心病者LVEF-R≤0可独立识别90天血运重建生存获益者,而已知冠心病者LVEF-R无预后价值。
要点
- PET负荷LVEF-R≤0在无既往冠心病者中识别血运重建生存获益。
- 已知冠心病患者中LVEF-R对死亡无预后价值(HR 0.99)。
- 多参数PET评估缺血可优化血运重建后管理。
核心结论
- 在无既往心肌梗死或血运重建的患者中,血管扩张剂负荷PET MPI示LVEF无增幅或下降独立识别90天内血运重建较药物治疗生存更优者。
研究设计与样本
- 回顾性队列研究,纳入2010年1月至2016年1月连续14,649例接受82Rb静息/负荷PET MPI的独特患者,排除已知心肌病。
主要发现
- 已知冠心病4,982例(34.0%),检出缺血5,396例(36.8%;≥10%者1,909例[13%])。
- 平均LVEF-R为4.2%±5.7%,≤0、1-5、>5者分别为3,349例(22.9%)、5,266例(35.9%)、6,034例(41.2%)。
- 中位随访3.4年(IQR 1.9-5.2年),90天血运重建1,324例(8.1%),死亡2,192例(15.0%)。
- 多变量模型示已知冠心病、LVEF-R与90天血运重建三阶交互作用显著(P=0.025);无既往冠心病者LVEF-R≤0与90天血运重建生存获益交互P=0.005,独立于缺血百分比和心肌血流储备。
- 已知冠心病者LVEF-R对死亡无预后价值(HR 0.99;95%CI 0.98-1.02;P=0.98)。
临床怎么用
- 对无既往冠心病者,PET MPI示LVEF-R≤0可支持90天内血运重建以改善生存的决策。
- 已知冠心病者不应依据LVEF-R判断血运重建生存获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Positron emission tomography (PET) myocardial perfusion imaging (MPI) quantifies left ventricular ejection fraction (LVEF) at peak stress. PET LVEF reserve (LVEF-R = stress LVEF - rest LVEF) offers diagnostic and prognostic value. OBJECTIVES: The purpose of this study was to determine if PET LVEF-R identifies patients with survival benefit postrevascularization. METHODS: We followed 14,649 unique consecutive patients undergoing 82Rb rest/stress PET MPI from January 2010 to January 2016 (excluding known cardiomyopathy). Adjusted Cox models were built to predict all-cause death, and the 3-way interaction of known coronary artery disease (CAD) (prior myocardial infarction/revascularization), LVEF-R, and 90-day revascularization was tested. RESULTS: Known CAD was present in 4,982 (34.0%). Ischemia was detected in 5,396 (36.8%; ≥10% in 1,909 [13%]). Mean LVEF-R was 4.2% ± 5.7%, and was ≤0, 1 to 5, and >5 in 3,349 (22.9%), 5,266 (35.9%), and 6,034 (41.2%). Over median follow-up of 3.4 years (IQR: 1.9-5.2 years), 1,324 (8.1%) had 90-day revascularization, and there were 2,192 (15.0%) deaths. In multivariable modeling, there was a significant 3-way interaction among known CAD, LVEF-R, and 90-day revascularization (P = 0.025), such that LVEF-R ≤0 identified patients with survival benefit with 90-day revascularization in those without prior CAD (interaction P = 0.005), independently beyond percent ischemia and myocardial flow reserve. Among patients with known CAD, LVEF-R was not prognostic of death (HR: 0.99; 95% CI: 0.98-1.02; P = 0.98). CONCLUSIONS: A lack of augmentation or drop in LVEF with vasodilator stress on PET MPI independently identifies patients who have better survival with revascularization within 90 days post-MPI compared with medical therapy, in absence of prior myocardial infarction or revascularization. Multiparametric assessment of ischemia with PET can optimize post-test management.
引用
- Patel KK, McGhie AI, Kennedy KF, et al. Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization. J Am Coll Cardiol. 2023. PMID: 37852696. doi:10.1016/j.jacc.2023.08.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。